Strain Selection and Statistical Optimization of Culture Conditions for 19F Polysaccharide Production from Pneumococcus

Shirin Tarahomjoo, Sedigheh Rafiei Tabatabaei, Abdollah Karimi, Mohammad Rahbar

Abstract


51

Introduction:  Capsular polysaccharides of pneumococci are principle antigenic constituents of vaccines against pneumococci. Enhancing the yield of capsule production decreases costs of these vaccines and increases the vaccine coverage in developing countries. In this study therefore, we aim to optimize the capsule production from serotype 19F pneumococcus in terms of the applied pneumococcal strain and environmental culture conditions.Materials and Methods:  Thirteen serotype 19F Streptococcus pneumoniae strains were screened for the capsule production in modified Hoeprich culture medium using the stains all assay. The optimal ranges of environmental culture conditions for the selected strain were determined using single factor at a time (SFAT) strategy and utilized for the design of experiments based on the response surface methodology (RSM).Results:  S. pneumoniae 82218 showed the highest capsule production, and thus used for further studies. The maximum capsule production (1.364 mg/ml) was attained under optimal conditions (pH 7.26, 35.5 ºC, 30 rpm) predicted by the RSM derived quadratic model. The capsule production under the optimal conditions increased to 1.9 mg/ml using the buffered culture medium. Conclusion:  These results are much higher than those reported for pneumococcal capsule production in published studies [1, 2] and thus can be used to design suitable systems for the serotype 19F capsule production in the vaccine manufacturing process. 



Keywords


single factor at a time; optimization; 19F polysaccharide; pneumococcal vaccines; response surface methodology; Streptococcus pneumoniae

Full Text:

PDF

196

References


Kim S, Min K, Choi I, Kim S, Pyo S and Rhee D (1996) Optimization of culture conditions for production of pneumococcal capsular polysaccharide type IV. Archives of Pharmacal Research 19:173-177.

Gonçalves V, Zangirolami T, Giordano R, Raw I, Tanizaki M and Giordano R (2002) Optimization of medium and cultivation conditions for capsular polysaccharide production by Streptococcus pneumoniae serotype 23F. Applied microbiology and biotechnology 59:713-717.

Mook-Kanamori BB, Geldhoff M, van der Poll T and van de Beek D (2011) Pathogenesis and pathophysiology of pneumococcal meningitis. Clinical microbiology reviews 24:557-591.

Publication W (2012) Pneumococcal vaccines WHO position paper–2012–recommendations. Vaccine 30:4717-4718.

Mera RM, Miller LA, Daniels JJ, Weil JG and White AR (2005) Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagnostic microbiology and infectious disease 51:195-200.

Appelbaum PC (2002) Resistance among Streptococcus pneumoniae: implications for drug selection. Clinical infectious diseases 34:1613-1620.

Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Abdolmaleki Z, Sedaghat H and Jonaidi N (2009) Antibiotic susceptibility pattern of gram-positive cocci cultured from patients in three university hospitals in Tehran, Iran during 2001-2005. Acta Medica Iranica 47:329-334.

Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, Collins M, Donohoe K, Harris D, Murphy L and Quail MA (2006) Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet 2:e31.

Melin M, Trzciński K, Antonio M, Meri S, Adegbola R, Kaijalainen T, Käyhty H and Väkeväinen M (2010) Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae. Infection and immunity 78:5252-5261.

Hyams C, Yuste J, Bax K, Camberlein E, Weiser JN and Brown JS (2010) Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype. Infection and immunity 78:716-725.

Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Hance LF, Reithinger R, Muenz LR and O'Brien KL (2010) Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 7:e1000348.

Mukherjee S, Das P and Sen R (2006) Towards commercial production of microbial surfactants. TRENDS in Biotechnology 24:509-515.

Kapoor M, Nair LM and Kuhad RC (2008) Cost-effective xylanase production from free and immobilized Bacillus pumilus strain MK001 and its application in saccharification of Prosopis juliflora. Biochemical Engineering Journal 38:88-97.

Massaldi H, Bessio MI, Suárez N, Texeira E, Rossi S and Ferreira F (2010) Features of bacterial growth and polysaccharide production of Streptococcus pneumoniae serotype 14. Biotechnology and applied biochemistry 55:37-43.

Jin S-D, Kim Y-M, Kang H-K, Jung S-J and Kim D (2009) Optimization of capsular polysaccharide production by Streptococcus pneumoniae type 3. Journal of microbiology and biotechnology 19:1374-1378.

Cimini D, Restaino OF, Catapano A, De Rosa M and Schiraldi C (2010) Production of capsular polysaccharide from Escherichia coli K4 for biotechnological applications. Applied microbiology and biotechnology 85:1779-1787.

Maldonado LMP, Hernández VEB, Rivero EM, de la Rosa APB, Flores JLF, Acevedo LGO and Rodríguez ADL (2007) Optimization of culture conditions for a synthetic gene expression in Escherichia coli using response surface methodology: the case of human interferon beta. Biomolecular engineering 24:217-222.

Morona JK, Morona R, Miller DC and Paton JC (2003) Mutational analysis of the carboxy-terminal (YGX) 4 repeat domain of CpsD, an autophosphorylating tyrosine kinase required for capsule biosynthesis in Streptococcus pneumoniae. Journal of bacteriology 185:3009-3019.

Plumptre CD, Ogunniyi AD and Paton JC (2013) Surface association of Pht proteins of Streptococcus pneumoniae. Infection and immunity 81:3644-3651.

García E, Llull D and López R (2010) Functional organization of the gene cluster involved in the synthesis of the pneumococcal capsule. International Microbiology 2:169-176.

Schaffner TO, Hinds J, Gould KA, Wüthrich D, Bruggmann R, Küffer M, Mühlemann K, Hilty M and Hathaway LJ (2014) A point mutation in cpsE renders Streptococcus pneumoniae nonencapsulated and enhances its growth, adherence and competence. BMC microbiology 14:210.

Carvalho SM, Andisi VF, Gradstedt H, Neef J, Kuipers OP, Neves AR and Bijlsma JJ (2013) Pyruvate oxidase influences the sugar utilization pattern and capsule production in Streptococcus pneumoniae. PloS one 8:e68277.

Rault A, Bouix M and Béal C (2008) Dynamic analysis of Lactobacillus delbrueckii subsp. bulgaricus CFL1 physiological characteristics during fermentation. Applied microbiology and biotechnology 81:559-570.

Merchuk JC (1991) Shear effects on suspended cells. Bioreactor systems and effects, Springer, pp. 65-95




DOI: https://doi.org/10.22037/jps.v10i1.22821

Refbacks

  • There are currently no refbacks.


"Journal of Paramdedical Sciences", is a publication of "School of Paramedical Sciences, Shahid Beheshti University of Medical Sciences" and "Iranian Society of Medical Proteomics".

"Journal of Paramdedical Sciences" is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

EISSN: 2008-4978

PISSN: 2008-496X